Gemcitabine in the Second-Line Therapy of Patients with Carcinoma of Unknown Primary Site: A Phase II Trial of the Minnie Pearl Cancer Research Network
- 1 January 2001
- journal article
- clinical trial
- Published by Taylor & Francis in Cancer Investigation
- Vol. 19 (4) , 335-339
- https://doi.org/10.1081/cnv-100103127
Abstract
The purpose of this study was to evaluate the activity ofsingle-agent gemcitabine in previously treated patients with carcinoma ofunknown primary site. Between January 1997 and October 1998, 39 pat...Keywords
This publication has 14 references indexed in Scilit:
- Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.Journal of Clinical Oncology, 1997
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Advanced breast cancer: a phase II trial with gemcitabine.Journal of Clinical Oncology, 1995
- Phase II Study of Gemcitabine (2',2'-Difluorodeoxycytidine) in Previously Treated Ovarian Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloro platinum in patients with metastatic carcinoma of unknown primary originAnnals of Oncology, 1991
- Fluorouracil, doxorubicin, cisplatin and altretamine in the treatment of metastatic carcinoma of unknown primaryEuropean Journal of Cancer and Clinical Oncology, 1989
- Lack of Value for Cisplatin Added to Mitomycin-Doxorubicin Combination Chemotherapy for Carcinoma of Unknown Primary Site A Randomized TrialAmerican Journal of Clinical Oncology, 1987
- Metastatic Adenocarcinomas of Unknown Primary SiteNew England Journal of Medicine, 1980
- Treatment of the patient with adenocarcinoma of unknown originCancer, 1972